Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Semaglutide

An analogue of GLP-1, the gut hormone that boosts insulin after meals: approved in 2017 for type 2 diabetes, in 2019 it became the first GLP-1 drug taken by mouth, and it is also used for weight management. This family brings together the active ingredient, labelled standards and other impurities.

Did you know?It is about 94% identical to human GLP-1, but a fatty acid chain binds it to albumin in the blood: it stays in circulation for about a week, so one injection a week is enough.

SemaglutideGo to the active ingredient →
SemaglutideActive ingredientSemaglutideCat. No. P-S031-001CAS 910463-68-2

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.